Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure (Q44588532)

4 December 2017

Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure (English)

1 reference

4 December 2017

1 reference

Luciano Dalla Libera

1

1 reference

4 December 2017

Barbara Ravara

2

1 reference

4 December 2017

Maurizio Volterrani

3

1 reference

4 December 2017

Valerio Gobbo

4

1 reference

4 December 2017

Mila Della Barbera

5

1 reference

4 December 2017

Annalisa Angelini

6

1 reference

4 December 2017

Daniela Danieli Betto

7

1 reference

4 December 2017

Elena Germinario

8

1 reference

4 December 2017

Giorgio Vescovo

9

1 reference

4 December 2017

17 September 2003

1 reference

American Journal of Physiology - Cell Physiology

4 December 2017

1 reference

4 December 2017

286

1 reference

4 December 2017

1

1 reference

4 December 2017

C138-44

1 reference

Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone.

4 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Symptoms and quality of life in heart failure: the muscle hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

A placebo-controlled study of growth hormone in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Contractile properties of in situ perfused skeletal muscles from rats with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

Growth hormone improves cardiac performance in experimental heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00114.2003

10.1152/AJPCELL.00114.2003

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference